Global Travel Vaccines Market growing at a CAGR of 10.2% from 2023 to 2030
Category : Healthcare | Published Date : Jun 2023 | Type : Press Release
Key Market Overview
Consegic Business Intelligence analyzes that the travel vaccines market is growing with a CAGR of 10.2% and is expected to reach 7,137.89 million in 2030 from USD 3,290.00 Million in 2022.
The report highlights the governmental policies and regulations to promote the adoption of travel vaccines. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the travel vaccines market.
Global Travel Vaccines Market By Overview
The travel vaccines market is bifurcated into composition, disease type, and traveler type. Based on composition, the market is segmented into mono vaccines and combination vaccines. In 2022, the mono vaccines segment dominate in the overall travel vaccines market. The disease type segment is categorized into hepatitis A, dpt, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, Japanese encephalitis, and others. In 2022, the hepatitis A segment accounted for the highest market share in the travel vaccines market. Based on traveler type, the market is segmented into inbound and outbound. In 2022, the inbound segment dominate in the overall travel vaccines market.
Get Free SampleMarket Dynamics
Driver:
- Governmental policies and regulations to promote the adoption of travel vaccines are boosting the market growth of travel vaccines.
- The growing tourism industry is propelling the growth of the travel vaccines market.
Restraints:
- The high cost of travel vaccines particularly during the administration of multiple doses or booster shots is likely to hinder market growth.
Market Segmentation:
| Report Attributes | Report Details |
| By Composition | Mono Vaccines and Combination Vaccines |
| By Disease Type | Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Japanese Encephalitis, and Others |
| By Traveler Type | Inbound and Outbound |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Competitive Landscape :
As per the study, the market is dominated by certain major companies such as GSK plc., Sanofi, and Merck & Co., Inc. have a strong market position in current market circumstances. Further, the travel vaccines market is expected to witness significant growth in the coming years due to the rising development of the pharmaceutical and food & beverage industries. The market players compete for a firm market position through mergers and acquisitions, product innovations, and business strategies. Thus, evolving research and developments are expected to help market players adopt innovative ways of product creation to cater to the growing needs of various end-use industries.
- GSK plc.
- Sanofi
- Merck & Co., Inc.
- Pfizer Inc.
- Bavarian Nordic
- Emergent
- Seqirus
- Valneva SE
- Abbott
- AstraZeneca
